Announce Date | 04/30/2025 |
EPS Normalized Actual | $3.53 (Beat by $1.01) |
EPS GAAP Actual | $3.53 (Beat by $1.01) |
Revenue Actual | $16.452B |
Revenue Surprise | Beat by $16452M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.82698 |
EPS GAAP Estimate | $2.82698 |
Revenue Estimate | $15.484458625B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 24.84962 | 7.97 | 23.37888 | 25.9041 | 1 |
Dec 2026 | 16.78962 | 11.79 | 8.78 | 20.95 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | 0 | 16.452B | 7.25% | 16452M |
FQ4 2024 (Dec 2024) | 0 | 0 | 16.506B | 10.14% | 16506M |
FQ3 2024 (Sep 2024) | 4.39 | 4.39 | 16.627B | 20.56% | 16627M |
FQ2 2024 (Jun 2024) | 0 | 0 | 15.714B | 11.04% | 15714M |
FQ1 2024 (Mar 2024) | 0 | 0 | 15.259B | 19.15% | 15259M |
FQ4 2023 (Dec 2023) | 0 | 0 | 14.832B | 7.99% | 14832M |
FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 13.208B | 0% | 13208M |
FQ2 2023 (Jun 2023) | -5.15 | -5.15 | 13.979B | 12.58% | 13979M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.82698
Consensus Revenue Estimates
15.484458625B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 8.36316 | -- | 8.26569 | 8.45841 | 4 |
FQ3 2027 (Sep 2027) | 6.03001 | -- | 5.95973 | 6.09869 | 7 |
FQ2 2027 (Jun 2027) | 3.55578 | -- | 3.51434 | 3.59628 | 4 |
FQ1 2027 (Mar 2027) | 6.90067 | -- | 6.82025 | 6.97927 | 4 |
FQ4 2026 (Oct 2026) | 4.18345 | -- | 4.0228 | 4.29398 | 7 |
FQ3 2026 (Jul 2026) | 2.7473 | -- | 2.6418 | 2.81989 | 4 |
FQ2 2026 (Jun 2026) | 2.70098 | -- | 2.57103 | 2.99573 | 4 |
FQ1 2026 (Mar 2026) | 5.4194 | -- | 5.15866 | 6.01079 | 4 |
FQ4 2025 (Oct 2025) | 3.69778 | -- | 3.55578 | 3.79548 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 18.67B | -- | 18.5B | 18.83B | 1 |
FQ3 2027 (Sep 2027) | 19.74B | -- | 19.56B | 19.91B | 1 |
FQ2 2027 (Jun 2027) | 18.97B | -- | 18.8B | 19.14B | 1 |
FQ1 2027 (Mar 2027) | 17.35B | -- | 17.2B | 17.5B | 1 |
FQ4 2026 (Oct 2026) | 17.79B | -- | 17.27B | 18.15B | 1 |
FQ3 2026 (Jul 2026) | 16.89B | -- | 16.4B | 17.24B | 1 |
FQ2 2026 (Jun 2026) | 17.16B | -- | 16.52B | 18.6B | 1 |
FQ1 2026 (Mar 2026) | 16.16B | -1.82 | 15.56B | 17.51B | 1 |
FQ4 2025 (Oct 2025) | 16.32B | -1.15 | 15.84B | 16.65B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
2
EPS # of in-lines
5
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 4.39 | 4.39 | 100% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 100% | |
FQ2 2023 (Jun 2023) | -5.15 | -5.15 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $16.45B | $16452M | 100% |
FQ4 2024 (Dec 2024) | $0B | $16.51B | $16506M | 100% |
FQ3 2024 (Sep 2024) | $0B | $16.63B | $16627M | 100% |
FQ2 2024 (Jun 2024) | $0B | $15.71B | $15714M | 100% |
FQ1 2024 (Mar 2024) | $0B | $15.26B | $15259M | 100% |
FQ4 2023 (Dec 2023) | $0B | $14.83B | $14832M | 100% |
FQ3 2023 (Sep 2023) | $0B | $13.21B | $13208M | 100% |
FQ2 2023 (Jun 2023) | $0B | $13.98B | $13979M | 100% |